World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
22216
World Ranking
18751
National Ranking
1695

Neil Barnes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neil Barnes sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 326 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neil Barnes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neil Barnes sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 76 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Neil Barnes is affiliated with GlaxoSmithKline in the United Kingdom. Their primary research focus lies within the field of Medicine, with a significant concentration on Pulmonary and Respiratory Medicine.

Their work encompasses several subfields, including Physiology, Surgery, Behavioral Neuroscience, and Molecular Biology, with notable emphasis on respiratory-related conditions and treatments.

Key topics covered by Neil Barnes include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • Respiratory Support and Mechanisms
  • Eosinophilic Esophagitis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

They have contributed to several recent publications, including:

  • Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial, 2020, The Lancet Respiratory Medicine
  • Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis, 2021, European Respiratory Journal
  • Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression, 2020, British Journal of Clinical Pharmacology
  • High eosinophil counts predict decline in FEV1: results from the CanCOLD study, 2020, European Respiratory Journal
  • A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients, 2020, European Respiratory Journal

The scientist frequently publishes in the following venues:

  • European Respiratory Journal
  • International Journal of COPD
  • CHEST Journal
  • Respiratory Medicine
  • Journal of Allergy and Clinical Immunology

Frequent co-authors collaborating with Neil Barnes include:

  • Dave Singh
  • Paul Jones
  • David A. Lipson
  • Edward Kerwin
  • Zelie Bailes

Best Publications

  • British guideline on the management of asthma: A national clinical guideline

    Graham Douglas;Bernard Higgins;Neil Barnes;Anne Boyter

  • Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

    Patrick Flood-Page;Andrew Menzies-Gow;Simon Phipps;Sun Ying

  • Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

    Terence C. O'shaughnessy;Tareq W. Ansari;Neil C. Barnes;Peter K. Jeffery

  • Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

    Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Mark T Dransfield;Neil C Barnes;Neil C Barnes

  • A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

    Patrick Flood-Page;Cheri Swenson;Isidore Faiferman;John Matthews

  • Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society

    KF Chung;P Godard;E Adelroth;J Ayres

  • Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

    Eric D Bateman;Gary T Ferguson;Neil Barnes;Nicola Gallagher

  • Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

    A.G. Alexander;A.B. Kay;N.C. Barnes

  • Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

    N C Barnes;P J Piper;J F Costello

  • Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

    Ian D Pavord;Sally Lettis;Nicholas Locantore;Steve Pascoe

  • The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

    Keith L. Hattotuwa;Mariusz J. Gizycki;Tareq W. Ansari;Peter K. Jeffery

  • Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

    C. J. Corrigan;P. H. Brown;N. C. Barnes;S. J. Szefler

  • Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease

    Neil C. Barnes;Yu-Sheng Qiu;Ian D. Pavord;Debbie Parker

  • Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial

    Adrian R Martineau;Wai Yee James;Richard L Hooper;Neil C Barnes

  • COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

    Monica J Fletcher;Jane Upton;Judith Taylor-Fishwick;Sonia A Buist

  • A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

    N. Barnes;I. Pavord;A. Chuchalin;J. Bell

  • Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

    Christopher H Compton;Jason Gubb;Richard Nieman;Jeffrey Edelson

  • Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

    K.P. Hui;N.C. Barnes

  • Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease

    Elizabeth Gamble;Diana C. Grootendorst;Christopher E. Brightling;Susannah Troy

  • Difficult/therapy-resistant asthma The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies ERS Task Force on Difficult/Therapy-Resistant Asthma

    P. Godard;E. Adelroth;J. Ayres;N. Barnes

Frequent Co-Authors

Ian D. Pavord
Ian D. Pavord University of Oxford
Nicolas Roche
Nicolas Roche Université Paris Cité
Steffen E. Petersen
Steffen E. Petersen Queen Mary University of London
Christopher Corrigan
Christopher Corrigan King's College London
David Price
David Price University of Aberdeen
Alberto Papi
Alberto Papi University of Ferrara
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Amanda J. Lee
Amanda J. Lee University of Aberdeen
Paul W. Jones
Paul W. Jones St George's, University of London
Guy Brusselle
Guy Brusselle Ghent University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, there are several flexible online pathways that can launch or advance your healthcare career. For those interested in patient care or looking for a cost-effective start, online nursing programs offer accredited coursework and robust clinical experiences without the need to relocate or pause your career.

Nurses who wish to advance their qualifications can look into the cheapest dnp programs online, which provide a fast track to leadership or advanced clinical roles at an affordable rate. Registered nurses aiming for more senior positions will benefit from researching the cheapest rn to bsn program to upgrade their credentials with maximum flexibility and minimal financial burden.

If you hold a bachelor’s degree in another field and are considering a direct move into nursing, accelerated options like a direct entry msn online can help you quickly transition into advanced nursing practice. These pathways support varied career ambitions in healthcare, making it possible to advance on your own schedule and within your budget.

Best Scientists Citing Neil Barnes

Trending Scientists

Recently Published Articles